4.2 Article

Newer disease modifying treatments in pediatric onset multiple sclerosis: Experience from a single center

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

Tanuja Chitnis et al.

Summary: The TERIKIDS study investigated the safety and efficacy of teriflunomide in children with relapsing multiple sclerosis. The study showed that teriflunomide could significantly reduce the risk of focal inflammatory activity in pediatric patients with relapsing multiple sclerosis compared to placebo.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Omar A. Abdel-mannan et al.

Summary: The study found that newer disease-modifying therapies (DMTs) were associated with lower risk of clinical and radiologic relapses in children with relapsing-remitting multiple sclerosis (RRMS) compared to injectables. Multivariable analysis showed injectables were linked to increased risk of clinical relapse and new radiologic activity, supporting the argument for a shift towards more efficacious DMTs.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Article Clinical Neurology

Predictors of treatment outcome in patients with paediatric onset multiple sclerosis

Tine Iskov Kopp et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Cognitive functions in pediatric multiple sclerosis: 2-years follow-up

Zeynep Ozturk et al.

NEUROLOGICAL RESEARCH (2020)

Article Clinical Neurology

Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis

Kristen M. Krysko et al.

ANNALS OF NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Current Advances in Pediatric Onset Multiple Sclerosis

Kristen S. Fisher et al.

BIOMEDICINES (2020)

Article Clinical Neurology

Therapy of highly active pediatric multiple sclerosis

Peter Huppke et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Article Clinical Neurology

Therapy of highly active pediatric multiple sclerosis

Peter Huppke et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Review Clinical Neurology

Paediatric multiple sclerosis: a new era in diagnosis and treatment

Sophie Duignan et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)

Review Clinical Neurology

Treatment in childhood central nervous system demyelinating disorders

Bahadir Konuskan et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)

Review Clinical Neurology

Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis

Gabrielle Macaron et al.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)

Article Clinical Neurology

Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis

A. Johnen et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2019)

Article Medicine, General & Internal

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J. William L. Brown et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Article Medicine, General & Internal

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Tanuja Chitnis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Clinical Neurology

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up

Carrie M. Hersh et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)

Editorial Material Clinical Neurology

Disease Activity Free Status A New End Point for a New Era in Multiple Sclerosis Clinical Research?

Carolyn J. Bevan et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years

L. A. Benson et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)

Article Clinical Neurology

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis

T. Chitnis et al.

MULTIPLE SCLEROSIS JOURNAL (2012)

Article Clinical Neurology

Pediatric Multiple Sclerosis

Tanuja Chitnis et al.

NEUROLOGIC CLINICS (2011)

Article Clinical Neurology

Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study

Yann Mikaeloff et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)

Article Medicine, General & Internal

Natural history of multiple sclerosis with childhood onset

Christel Renoux et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)